Phase II Study of Amrubicin Combined with Carboplatin for Thymic Carcinoma and Invasive Thymoma: North Japan Lung Cancer Group Study 0803-Reference-Cited by-同舟云学术

Phase II Study of Amrubicin Combined with Carboplatin for Thymic Carcinoma and Invasive Thymoma: North Japan Lung Cancer Group Study 0803

Published:2014-12 Issue:12 Volume:9 Page:1805-1809
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Inoue Akira,Sugawara Shunichi,Harada Masao,Kobayashi Kunihiko,Kozuki Toshiyuki,Kuyama Shoichi,Maemondo Makoto,Asahina Hajime,Hisamoto Akiko,Nakagawa Taku,Hotta Katsuyuki,Nukiwa Toshihiro

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. Thymic carcinoma: state of the art review;Eng;Int J Radiat Oncol Biol Phys,2004

2. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group;Loehrer;J Clin Oncol,1994

3. Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study;Yana;Invest New Drugs,2007

4. A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer;Inoue;J Thorac Oncol,2006

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymic epithelial tumor medical treatment: A narrative review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. The remarkable antitumor efficacy of corticosteroid treatment in patients with refractory thymomas;Respiratory Investigation;2024-09

3. Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101);Clinical Lung Cancer;2023-11

4. Efficacy and safety of treatments for advanced thymic carcinoma after failure of first-line platinum-based chemotherapy: A systematic literature review and meta-analysis;Lung Cancer;2023-02

5. Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma;Investigational New Drugs;2023-01-12